ioversol has been researched along with avapro in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ding, GH; Jia, RH; Xiong, XL; Yang, DP | 1 |
1 review(s) available for ioversol and avapro
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ioversol and avapro
Article | Year |
---|---|
Irbesartan attenuates contrast media-induced NRK-52E cells apoptosis.
Topics: Animals; Annexin A5; Antihypertensive Agents; Apoptosis; Biphenyl Compounds; Bisbenzimidazole; Cell Line; Coloring Agents; Contrast Media; Enzyme Inhibitors; Genes, bcl-2; Indicators and Reagents; Irbesartan; Oxidative Stress; Propidium; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Triiodobenzoic Acids | 2006 |